Johnson & Johnson (NYSE:JNJ) is one of the best medical stocks to buy now. In a report released on September 30, Matt Miksic from Barclays maintained a Hold rating on Johnson & Johnson (NYSE:JNJ) and set a price target of $176.00. Johnson & Johnson (NYSE:JNJ) develops, manufactures, and sells products in the healthcare field. While we acknowledge the potential of JNJ as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.